BrainBrew Intranasal Drug and Delivery Device

The government authority located in California requires a vendor to provide the BrainBrew intranasal drug and delivery device. The requested scope includes end-to-end development services to design, prototype, and manufacture the intranasal drug-delivery device paired with the formulation and qualification of the Cognic-E nutraceutical aqueous small molecule drug source. Services encompass Phase 1 concept and feasibility, Phase 2 device engineering, design for manufacturing, drug qualification, and formulation, and Phase 3 prototype development, testing, labeling, packaging, and production of 15 functional GMP device-drug prototypes for bench testing, formulation compatibility, reproducibility, and user-handling studies. The buyer limits eligibility to USA organizations and requires onsite performance of the work. Vendors may submit responses digitally via email or online, and the buyer requests budget proposals. A pre-bid meeting occurs on September 2, 2026, and bidders must submit all questions no later than September 7, 2026. Evaluation criteria are not provided.